These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27008812)

  • 41. Galactose functionalized injectable thermoresponsive microgels for sustained protein release.
    Lou SF; Wang L; Williams GR; Nie H; Quan J; Zhu L
    Colloids Surf B Biointerfaces; 2014 Jan; 113():368-74. PubMed ID: 24121080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A 12-week subchronic intramuscular toxicity study of risperidone-loaded microspheres in rats.
    Zhang J; Ye L; Wang W; Du G; Yu X; Zhu X; Dong Q; Cen X; Guan X; Fu F; Tian J
    Hum Exp Toxicol; 2015 Feb; 34(2):205-23. PubMed ID: 24812153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review.
    Cañas F; Möller HJ
    Expert Opin Drug Saf; 2010 Sep; 9(5):683-97. PubMed ID: 20690885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "Long-acting" olanzapine in maintenance therapy of schizophrenia: A study with plasma levels.
    Mauri MC; Maffini M; Di Pace C; Reggiori A; Paletta S; Moliterno D; Rovera C; Altamura CA
    Int J Psychiatry Clin Pract; 2015 Jun; 19(2):99-105. PubMed ID: 25547438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Switching depot antipsychotic drug responders to oral olanzapine.
    Godleski LS; Goldsmith LJ; Vieweg WV; Zettwoch N; Stikovac D; Lewis S
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):141-4. PubMed ID: 15610956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Temperature-sensitive poly(vinyl alcohol)/poly(methacrylate-co-N-isopropyl acrylamide) microgels for doxorubicin delivery.
    Ghugare SV; Mozetic P; Paradossi G
    Biomacromolecules; 2009 Jun; 10(6):1589-96. PubMed ID: 19425550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanoencapsulation of olanzapine increases its efficacy in antipsychotic treatment and reduces adverse effects.
    Dimer FA; Ortiz M; Pase CS; Roversi K; Friedrich RB; Pohlmann AR; Burger ME; Guterres SS
    J Biomed Nanotechnol; 2014 Jun; 10(6):1137-45. PubMed ID: 24749408
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of olanzapine long-acting injection and oral olanzapine: a 2-year, randomized, open-label study in outpatients with schizophrenia.
    Detke HC; Weiden PJ; Llorca PM; Choukour M; Watson SB; Brunner E; Ascher-Svanum H
    J Clin Psychopharmacol; 2014 Aug; 34(4):426-34. PubMed ID: 24781441
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucosamine-carrying temperature- and pH-sensitive microgels: preparation, characterization, and in vitro drug release studies.
    Teng D; Hou J; Zhang X; Wang X; Wang Z; Li C
    J Colloid Interface Sci; 2008 Jun; 322(1):333-41. PubMed ID: 18417145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson's disease.
    Jiang Y; Zhang X; Mu H; Hua H; Duan D; Yan X; Wang Y; Meng Q; Lu X; Wang A; Liu W; Li Y; Sun K
    Drug Deliv; 2018 Nov; 25(1):143-152. PubMed ID: 29275639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Olanzapine pamoate: a stick in time? A review of the efficacy and safety profile of a new depot formulation of a second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2009 Jan; 63(1):140-50. PubMed ID: 18834452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mucoadhesive Amphiphilic Methacrylic Copolymer-Functionalized Poly(ε-caprolactone) Nanocapsules for Nose-to-Brain Delivery of Olanzapine.
    Fonseca FN; Betti AH; Carvalho FC; Gremião MP; Dimer FA; Guterres SS; Tebaldi ML; Rates SM; Pohlmann AR
    J Biomed Nanotechnol; 2015 Aug; 11(8):1472-81. PubMed ID: 26295147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of two formulations of oral olanzapine in patients with schizophrenia or bipolar disorder in a natural setting: results from a 1-year European observational study.
    Kraemer S; Chartier F; Augendre-Ferrante B; Psarra V; D'yachkova Y; Beselin A; Rouillon F
    Hum Psychopharmacol; 2012 May; 27(3):284-94. PubMed ID: 22473831
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surgically implantable long-term antipsychotic delivery systems for the treatment of schizophrenia.
    Siegel SJ; Winey KI; Gur RE; Lenox RH; Bilker WB; Ikeda D; Gandhi N; Zhang WX
    Neuropsychopharmacology; 2002 Jun; 26(6):817-23. PubMed ID: 12007752
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formulation and characterization of nanoemulsion of olanzapine for intranasal delivery.
    Kumar M; Misra A; Pathak K
    PDA J Pharm Sci Technol; 2009; 63(6):501-11. PubMed ID: 20169856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Construction and evaluation of a phospholipid-based phase transition in situ gel system for brexpiprazole.
    Tao R; Liu L; Xiong Y; Zhang Q; Lv X; He L; Ren F; Zhou L; Chen B; Wu K; Zhang Y; Chen H
    Drug Deliv Transl Res; 2023 Nov; 13(11):2819-2833. PubMed ID: 37160629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Injectable long-term control-released in situ gels of hydrochloric thiothixene for the treatment of schizophrenia: preparation, in vitro and in vivo evaluation.
    Xin C; Lihong W; Qiuyuan L; Hongzhuo L
    Int J Pharm; 2014 Jul; 469(1):23-30. PubMed ID: 24751344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose correspondence between olanzapine long-acting injection and oral olanzapine: recommendations for switching.
    Detke HC; Zhao F; Garhyan P; Carlson J; McDonnell D
    Int Clin Psychopharmacol; 2011 Jan; 26(1):35-42. PubMed ID: 20948432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparation and characterization of PEM-coated alginate microgels for controlled release of protein.
    Zuo Q; Lu J; Hong A; Zhong D; Xie S; Liu Q; Huang Y; Shi Y; He L; Xue W
    Biomed Mater; 2012 Jun; 7(3):035012. PubMed ID: 22475630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.